179 related articles for article (PubMed ID: 3490381)
41. Myocardial 11C-palmitate kinetics in patients with coronary heart disease. Effect of non-insulin dependent diabetes mellitus.
Voipio-Pulkki LM; Ruotsalainen U; Nuutila P; Någren K
Acta Radiol Suppl; 1991; 376():142-3. PubMed ID: 1666753
[No Abstract] [Full Text] [Related]
42. Cardiac positron tomography.
Geltman EM; Sobel BE
Chest; 1983 Mar; 83(3):553-7. PubMed ID: 6337788
[No Abstract] [Full Text] [Related]
43. Synthesis and preliminary evaluation of (18)F-labeled 4-thia palmitate as a PET tracer of myocardial fatty acid oxidation.
DeGrado TR; Wang S; Holden JE; Nickles RJ; Taylor M; Stone CK
Nucl Med Biol; 2000 Apr; 27(3):221-31. PubMed ID: 10832078
[TBL] [Abstract][Full Text] [Related]
44. External detection and visualization of myocardial ischemia with 11C-substrates in vitro and in vivo.
Weiss ES; Hoffman EJ; Phelps ME; Welch MJ; Henry PD; Ter-Pogossian MM; Sobel BE
Circ Res; 1976 Jul; 39(1):24-32. PubMed ID: 776436
[TBL] [Abstract][Full Text] [Related]
45. Substrate use in ischemic and reperfused canine myocardium: quantitative considerations.
Myears DW; Sobel BE; Bergmann SR
Am J Physiol; 1987 Jul; 253(1 Pt 2):H107-14. PubMed ID: 3605356
[TBL] [Abstract][Full Text] [Related]
46. [Positron emission tomography: the prospects for studying myocardial metabolism in vivo].
Ashmarin IIu
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(2):103-7. PubMed ID: 6391515
[No Abstract] [Full Text] [Related]
47. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid.
Turpeinen AK; Takala TO; Nuutila P; Axelin T; Luotolahti M; Haaparanta M; Bergman J; Hämäläinen H; Iida H; Mäki M; Uusitupa MI; Knuuti J
Diabetes; 1999 Jun; 48(6):1245-50. PubMed ID: 10342811
[TBL] [Abstract][Full Text] [Related]
48. Myocardial imaging with radiolabeled free fatty acids: applications and limitations.
van der Wall EE
Eur J Nucl Med; 1986; 12 Suppl():S11-5. PubMed ID: 3490370
[TBL] [Abstract][Full Text] [Related]
49. Metabolism of [1-11C]palmitate in the diabetic heart studied in a porcine model using positron emission tomography.
Hartvig P; Waldenström A; Wikström G; Zielinski T; Martinussen HJ; Carlsten J; Voipio-Pulkki LM; Lundqvist H; Bjurling P; Någren K
Acta Radiol Suppl; 1991; 376():137-8. PubMed ID: 1666751
[No Abstract] [Full Text] [Related]
50. Metabolic and ultrastructural abnormalities during ischemia in canine myocardium: noninvasive assessment by positron emission tomography.
Schwaiger M; Fishbein MC; Block M; Wijns W; Selin C; Phelps ME; Schelbert HR
J Mol Cell Cardiol; 1987 Mar; 19(3):259-69. PubMed ID: 3496462
[TBL] [Abstract][Full Text] [Related]
51. Localization of viable, ischemic myocardium by positron-emission tomography with 11C-palmitate.
Lerch RA; Ambos HD; Bergmann SR; Welch MJ; Ter-Pogossian MM; Sobel BE
Circulation; 1981 Oct; 64(4):689-99. PubMed ID: 6974061
[No Abstract] [Full Text] [Related]
52. Positron-emission tomography: assessment of myocardial blood flow and metabolism.
Schelbert HR
Circulation; 1985 Nov; 72(5 Pt 2):IV122-33. PubMed ID: 3902283
[No Abstract] [Full Text] [Related]
53. Retention and clearance of C-11 palmitic acid in ischemic and reperfused canine myocardium.
Schwaiger M; Schelbert HR; Keen R; Vinten-Johansen J; Hansen H; Selin C; Barrio J; Huang SC; Phelps ME
J Am Coll Cardiol; 1985 Aug; 6(2):311-20. PubMed ID: 4019919
[TBL] [Abstract][Full Text] [Related]
54. Efflux of metabolized and nonmetabolized fatty acid from canine myocardium. Implications for quantifying myocardial metabolism tomographically.
Fox KA; Abendschein DR; Ambos HD; Sobel BE; Bergmann SR
Circ Res; 1985 Aug; 57(2):232-43. PubMed ID: 4017196
[TBL] [Abstract][Full Text] [Related]
55. Effects of dichloroacetate on the metabolism of glucose, pyruvate, acetate, 3-hydroxybutyrate and palmitate in rat diaphragm and heart muscle in vitro and on extraction of glucose, lactate, pyruvate and free fatty acids by dog heart in vivo.
McAllister A; Allison SP; Randle PJ
Biochem J; 1973 Aug; 134(4):1067-81. PubMed ID: 4762752
[TBL] [Abstract][Full Text] [Related]
56. Regional assessment of myocardial metabolic integrity in vivo by positron-emission tomography with 11C-labeled palmitate.
Ter-Pogossian MM; Klein MS; Markham J; Roberts R; Sobel BE
Circulation; 1980 Feb; 61(2):242-55. PubMed ID: 6965365
[No Abstract] [Full Text] [Related]
57. Delineation of myocardial oxygen utilization with carbon-11-labeled acetate.
Brown M; Marshall DR; Sobel BE; Bergmann SR
Circulation; 1987 Sep; 76(3):687-96. PubMed ID: 3113765
[TBL] [Abstract][Full Text] [Related]
58. Non-invasive regional assessment of myocardium with positron-emitting radionuclides.
Sobel BE
Adv Cardiol; 1979; 26():15-29. PubMed ID: 420059
[No Abstract] [Full Text] [Related]
59. Imaging of myocardial metabolism by positron emission tomography.
Rigo P; de Landsheere C; Melon P; Kulbertus H
Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 4():847-51. PubMed ID: 2093380
[TBL] [Abstract][Full Text] [Related]
60. Metabolism and blood flow as new markers of myocardial viability in the evolution of myocardial infarction.
Schwaiger M
Eur J Nucl Med; 1986; 12 Suppl():S62-5. PubMed ID: 3490380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
